TAT 2018 - Targeted Anticancer Therapies

Oncology Meeting Resources

05 Mar - 07 Mar 2018, Paris, France

TAT 2018

TAT 2018 - Targeted Anticancer Therapies focuses on early-phase development and translational research. The programme covered targeted agents, immuno-oncology and combinations involving such agents. Presentations and webcasts from the TAT 2018 - Targeted Anticancer Therapies are available here to ESMO members.

Watch ESMO video reports from experts:

The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity. Meeting programme | Future ESMO meetings





Format available

https://oncologypro.esmo.org/Meeting-Resour...ed-Anticancer-Therapies/ESMO-Welcome-address

Date: 05 Mar 2018
Presenter: Josep Tabernero
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...icancer-Therapies-Scientific-Welcome-address

Date: 05 Mar 2018
Presenter: Giuseppe Giaccone
Resources: Webcast

https://oncologypro.esmo.org/Meeting-Resour...Targeted-Anticancer-Therapies-Honorary-Award

Date: 05 Mar 2018
Presenter: Giuseppe Giaccone
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...cer-Therapies-Honorary-Award-Keynote-Address

Date: 05 Mar 2018
Presenter: Jean-Charles Soria
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...-drugs-targeting-IDO1-functions-in-neoplasia

Catabolism of amino acids is an ancient survival strategy that also controls immune responses in mammals. Indoleamine 2,3-dioxygenase 1 (IDO1), a tryptophan catabolizing enzyme, is recognized as an...

Date: 05 Mar 2018
Presenter: Francesca Fallarino
Resources: Abstract, Presentation
Topic: Anti-Cancer Agents & Biologic Therapy

https://oncologypro.esmo.org/Meeting-Resour...TAT-2018-Targeted-Anticancer-Therapies/CD137

Date: 05 Mar 2018
Presenter: Ignacio Melero
Resources: Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

https://oncologypro.esmo.org/Meeting-Resour...8-Targeted-Anticancer-Therapies/Introduction

Date: 05 Mar 2018
Presenter: Susan Bates
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...hibitor-tazemetostat-in-INI1-negative-tumors

Date: 05 Mar 2018
Presenter: Antoine Italiano
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...Targeting-histone-H3K36me3-deficient-cancers

SETD2-dependent histone H3 lysine 36 trimethylation (H3K36me3) plays a central role in both maintaining genome stability and in suppressing tumorigenesis, and is frequently depleted in particular cancer types.

Date: 05 Mar 2018
Presenter: Timothy Humphrey
Resources: Abstract, Presentation, Webcast
Topic: Anti-Cancer Agents & Biologic Therapy

https://oncologypro.esmo.org/Meeting-Resour...d-Anticancer-Therapies/BET-domain-inhibitors

Date: 05 Mar 2018
Presenter: Irene Brana Garcia
Resources: Presentation, Webcast